Information was received from a foreign health care provider (hcp) via a manufacturer representative regarding a patient who received clonidine (600.0mcg/ml, 149.96mcg/day) in an implantable pump for an unknown indication for use.The patient medical history and concomitant medications were unable to be obtained.Two hours following a refill on (b)(6) 2018 (approximately 16:30), the patient experienced vomiting, nausea, sleepiness (also reported as tired), vertigo, bradycardia, dry mouth, and did not feel well.The pump was emptied and 3.4ml of drug was missing.The expected reservoir volume (erv) was 39.9ml and the actual reservoir volume (arv) was 36.5ml(confirmed via provided session report).The issue was considered to be due to a pocket fill.There were no known environmental/external/patient factors that may have led or contributed to the issue.The refill was considered normal and nothing was noticed (in agreement with telemetry).The provide telemetry report from the refill indicated the erv was 17.3ml and the arv was 17.5ml.The pump was programmed to minimum rate.The patient was kept for monitoring.On (b)(6) 2018, the patient had no issue through the night.The patient was discharged and programming was resumed to clonidine 150mcg/day (plus 3 x 19.99mcg bolus).The issue was considered resolved.The status of the patient was stated to be alive and with no injury.No further complications were reported/anticipated.
|